112 results
Page 3 of 6
8-K
EX-10.1
jj57whntnpjjf3ljo i5
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-2.1
93m7m2hz
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
424B5
tttt1h
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-10.1
44cpyb3f3jksua2scgx
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.2
wurj gou33mrmvjbs3l
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
9fx32z g5
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
8-K
EX-99.1
qow8jxqmzvlhlz57 00
27 May 21
Regulation FD Disclosure
7:01am
8-K
EX-10.3
ro4mezq 6w
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
iy0v jhirtaid
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am